Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581.

Venook, A. P.,Niedzwiecki, D.,Lopatin, M.,Ye, X.,Lee, M.,Friedman, P. N.,Frankel, W.,Clark-Langone, K.,Millward, C.,Shak, S.,Goldberg, R. M.,Mahmoud, N. N.,Warren, R. ...; J. Clin. Oncol.. 2013 May 10.

Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.

Lasota, J., Wasag, B., Dansonka-Mieszkowska, A., Karcz, D., Millward, C.L., Ry??, J., Stachura, J., Sobin, L.H., Miettinen, M.; Lab Invest. 2003 Sep.

Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics.

Baehner, R., Magrane, G., Balassanian, R., Chang, C., Millward, C., Wakil, A. E., Osorio, R. W., Waldman, F. M.; Hum Pathol. 2000 Nov.